Telemetry Investments’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Telemetry Investments’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$951K	Buy	130,262 +7,262	+6%	+$51.2K	2.22%	11
2022 Q3	$851K	Buy	123,000 +1,330	+1%	+$9.92K	1.39%	25
2022 Q2	$850K	Buy	121,670 +34,114	+39%	+$266K	1.3%	19
2022 Q1	$723K	Buy	87,556 +31,056	+55%	+$280K	1.16%	28
2021 Q4	$610K	Buy	56,500 +5,592	+11%	+$60.4K	0.8%	41
2021 Q3	$615K	Buy	50,908 +13,756	+37%	+$155K	0.84%	41
2021 Q2	$451K	Sell	37,152 -500	-1%	-$6.2K	0.63%	53
2021 Q1	$524K	Buy	+37,652	New	+$526K	0.59%	66

Other funds holding AMYT

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Aquilo Capital Management San Francisco, California $37.1M AUM 41.76% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return